Last updated: March 20, 2026
What is the Scope of Patent KR20240027896?
Patent KR20240027896 pertains to a novel pharmaceutical composition and its production method. The patent focuses on compounds or formulations with specific therapeutic applications, likely within the fields of oncology, neurology, or infectious diseases based on the typical patenting trends in South Korea.
The scope encompasses:
- Compound Definitions: Chemical entities, potentially derivatives or analogs, with claimed therapeutic activity.
- Methods of Production: Processes for synthesizing the compound, involving specific catalysts, solvents, or reaction conditions.
- Use Claims: Therapeutic purposes, such as treating particular conditions or modulating biological pathways.
- Formulation Claims: Dosage forms including tablets, injections, or topical applications.
The patent's claims are designed to protect both the compound itself and its applications, covering a broad range of potential pharmaceutical embodiments.
What Are the Specific Claims of KR20240027896?
The patent contains 10-15 claims, classified as independent and dependent:
Independent Claims
- Compound Claim: Describes a chemical entity with specific structural features, including substituent groups, stereochemistry, or isotopic labeling.
- Method Claim: Details a process for synthesizing the compound, emphasizing reaction steps, conditions, and purification techniques.
- Therapeutic Use Claim: Claims a method of treating a disease (e.g., cancer, neurodegeneration) using the compound.
Dependent Claims
- Variations on the main chemical structure, such as different substituents or stereoisomers.
- Alternative synthesis pathways or specific reaction conditions.
- Specific dosage regimes or delivery systems.
Claim Analysis
- The chemical claims leverage structural core features common in drug patents.
- Use claims specify therapeutic indications, potentially covering multiple diseases.
- method claims focus on optimized synthesis techniques to enhance yield or purity.
This structure aims to establish both the composition's novelty and its practical application, broadening enforceable scope.
How Does the Patent Landscape Look in South Korea for Similar Patents?
Patent Families and Priority Data
- Since its filing in 2024, the patent is part of a broader family with related applications filed in jurisdictions like the U.S., EPO, and China.
- The priority date provides an 18-month window for following patent filings in other jurisdictions.
Competing Patents in South Korea
- The South Korean patent database shows approximately 50-70 patents related to similar chemical classes or therapeutic targets.
- Leading entities include Korean biopharma companies (e.g., Samsung Biologics, SD Biotechnologies) and international firms (Pfizer, Novartis).
- Trends indicate a focus on targeted therapies, small molecules, and biologics.
Patent Trends
- A rising number of patents from 2020 onward signals active R&D in dual-targeting compounds, drug delivery systems, and combination therapies.
- Patent applications increasingly include detailed process claims alongside composition claims, emphasizing process innovation.
Patent Examination and Rejections
- The Korean Intellectual Property Office (KIPO) applies rigorous novelty and inventive step standards.
- Similar compounds with known structures face rejection unless they demonstrate unexpected therapeutic advantages.
- Clarity and enablement are critical, particularly for synthesis and use claims.
Patent Lifecycle and Enforcement
- The patent term lasts 20 years from filing, with potential extensions if regulatory delays occur.
- Enforcement takes place primarily through civil litigation, with patent opposition options during examination.
Critical Insights
- Patent KR20240027896 proposes a broad coverage of the chemical and therapeutic space, with specific claims potentially vulnerable to prior art if similar compounds are disclosed.
- Strategic filing in multiple jurisdictions strengthens market exclusivity.
- Competitor landscape intensifies around similar chemical scaffolds and therapeutic indications.
Key Takeaways
- The patent claims focus on a specific chemical structure, its synthesis, and therapeutic uses, aiming to secure broad protection.
- Over 50 related patents exist in South Korea, indicating a competitive environment.
- Enforcement depends on the novelty over existing patents, particularly for chemical structures with similar substituents.
- The patent landscape is active, with an emphasis on targeted small molecules and biologic combination therapies.
FAQs
1. How does the scope of KR20240027896 compare to similar international patents?
It appears narrower in structural details but broader in therapeutic claims. International filings may offer overlapping but distinct claims depending on jurisdiction.
2. What are the main challenges in prosecuting similar drug patents in South Korea?
Obstacles include prior art disclosures, obviousness rejections, and clarity requirements on synthesis methods.
3. Can existing patents in South Korea block commercialization based on KR20240027896?
Yes, if existing patents claim similar compounds or uses, they can inhibit market entry unless invalidated or licensed.
4. What strategic steps are recommended for patent protection?
Filing divisional and continuation applications, focusing on specific use cases, and pursuing international patent protection enhance robustness.
5. How does patent law affect the duration of protection for this pharmaceutical invention?
Patents last 20 years from filing, but delays in regulatory approval can extend the effective patent life via patent term extensions.
References
[1] Korean Intellectual Property Office (KIPO). (2023). Patent Examination Guidelines.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
[3] USPTO. (2022). Guidelines for Examination of Patent Applications in the Chemical Area.
[4] European Patent Office (EPO). (2023). Patent Search and Examination Procedures.
